14-day Premium Trial Subscription Try For FreeTry Free
Investment Analysts’ updated eps estimates for Tuesday, February 11th: Abeona Therapeutics (NASDAQ:ABEO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The
Rise and Aegon are done buying Seattle-area apartments together for the year, but Rise has another acquisition on the horizon.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE